(redirected from P-glycoprotein)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia, Wikipedia.
Related to P-glycoprotein: ABCB1
PGPPretty Good Privacy
PGPPhysician Group Practice (Medicare)
PGPPhysics of Geological Processes
PGPPassword Generator Protocol
PGPPretty Good Protection (encryption)
PGPPearl of Great Price
PGPProgram Parameter (File Name Extension)
PGPProcter & Gamble Productions
PGPPersonal Growth Plan
PGPPfizer Global Pharmaceuticals
PGPPayment Gateway Provider (electronic commerce)
PGPPower Generation Plant (various locations)
PGPPreemptive Goal Programming
PGPPower Generation Platform
PGPPreferred Gender Pronoun (liguistics)
PGPProcedures Generation Package
PGPPast Grand Patriarch (IOOF)
PGPPrivate Generating Plant
PGPFundación Pequeñas Grandes Personas (Little People of Chile)
PGPPrevious Glacial Period
PGPPerforated Ground Plane
PGPProtected Gold Participation Unit
PGPPretty Good Pigeons
PGPParti Gabonaise du Progres (Gabonese Party for Progress)
PGPPost Graduate Programme (India)
PGPP-Glycoprotein (biology)
PGPPro-Gun Progressive (politics)
PGPProcter & Gamble Pharmaceuticals, Inc.
References in periodicals archive ?
Also with warfarin; inhibits OCT2 and Torsades de pointes P-glycoprotein has occurred when given with some antiarrhythmics; bradycardia may occur when used with beta-blockers and calcium channel blockers.
Piperine has been shown to increase small intestine absorption surfaces and inhibit intestinal P-glycoprotein
Functional interactions between P-glycoprotein and CYP3A in drug metabolism.
They dont get in, because of P-glycoprotein, but this same protector also keeps out helpful therapeutics.
Conclusion: Proton pump inhibitors may alter P-glycoprotein expression in the gastrointestinal tract, and subsequently H.
This drug is recognized and transported by P-glycoprotein (P-gp) a drug transporter encoded by adenosine triphosphate-binding cassette subfamily B member 1 (ABCB1) in the blood brain barrier.
Ji, "BME, a novel compound of anthraquinone, down regulated P-glycoprotein expression in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells via generation of reactive oxygen species," Chemico-Biological Interactions, vol.
This P-glycoprotein and CYP3A inhibition by cannabinoids brings up the possibility for drug interactions and potential toxicity, particularly at a time of expanding medical marijuana laws throughout the country.
However, ABCB1 is highly polymorphic; the polymorphism of which may affect the expression and function of P-glycoprotein (P-gp) and thus can influence the drug disposition in the CNS, affecting efficacy and treatment outcomes.
a) Avoid coadministration of P-glycoprotein inducers.